abdominal pain burning
Posted by admin on 13 January, 2010
No comments yet
This item was filled under [ Most Popular ]
Two-Year Data From Phase 2 Trial Of Genzyme Gaucher Disease Oral Compound Suggest Continued Improvement Across All …
Genzyme Corporation (NASDAQ: GENZ) announced two-year follow-up data from patients enrolled in the phase 2 clinical trial for its investigational oral therapy for Gaucher disease type 1 known as eliglustat tartrate (formerly Genz-112638). Continued improvements were observed across all endpoints, including bone disease, at the two-year timepoint, compared with baseline. The two-year results were …
Best Home Gym Fat Burning Workout – TT Intermediate Workout B
